Page last updated: 2024-11-03

primaquine and Allergic Encephalomyelitis

primaquine has been researched along with Allergic Encephalomyelitis in 2 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Thome, R2
Casella, G1
Lotfi, N1
Ishikawa, LWL1
Wang, Q1
Ciric, B1
Zhang, GX1
Rostami, A1
Zanucoli, F1
Bonfanti, AP1
de Carvalho, AC1
Issayama, LK1
da Costa, TA1
Di Gangi, R1
Ferreira, IT1
Bombeiro, AL1
de Oliveira, AL1
Verinaud, L1

Other Studies

2 other studies available for primaquine and Allergic Encephalomyelitis

ArticleYear
Primaquine elicits Foxp3
    Journal of autoimmunity, 2020, Volume: 114

    Topics: Animals; Antimalarials; Autoimmunity; Dendritic Cells; Disease Models, Animal; Encephalomyelitis, Au

2020
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
    CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:12

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Calcium-Binding Proteins; Central Nervous S

2014